Cargando…
Impact of Coronavirus disease 2019 (COVID-19) on contraception use in 2020 and up until the end of April 2021 in France
OBJECTIVES: To assess the impact of the COVID-19 pandemic on the use of reimbursed contraceptives in France after 15 months of the pandemic, according to age-group and updating previous data only pertaining to the first lockdown (2 months). STUDY DESIGN: We conducted a national register-based study...
Autores principales: | Roland, Noémie, Drouin, Jérôme, Desplas, David, Duranteau, Lise, Cuenot, François, Dray-Spira, Rosemary, Weill, Alain, Zureik, Mahmoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714238/ https://www.ncbi.nlm.nih.gov/pubmed/34971603 http://dx.doi.org/10.1016/j.contraception.2021.12.002 |
Ejemplares similares
-
Impact of coronavirus disease 2019 on contraception use in France
por: Roland, Noémie, et al.
Publicado: (2023) -
Effects of the Coronavirus Disease 2019 (COVID-19) Lockdown on the Use of Contraceptives and Ovulation Inductors in France
por: Roland, Noémie, et al.
Publicado: (2021) -
Intravitreal Anti–Vascular Endothelial Growth Factor Use in France During the Coronavirus Disease 2019 Pandemic
por: Billioti de Gage, Sophie, et al.
Publicado: (2020) -
Impact de l’épidémie COVID-19 sur l'utilisation des contraceptifs en France en 2020 et jusqu'en avril 2021
por: Roland, N., et al.
Publicado: (2022) -
Profiles of copper intrauterine devices and levonorgestrel intrauterine systems users in France in 2019: A national observational population‐based study
por: Roland, Noémie, et al.
Publicado: (2022)